["{\n\"step_by_step_thinking\": \"The relevant documents suggest that pneumococcal vaccine PCV 23 polysaccharide has shown the best results in preventing severe processes in high-risk populations. Pneumonia caused by Streptococcus pneumoniae is still considerable, and prophylaxis with a polyvalent anti-pneumococcus vaccine would prevent such processes. The vaccine was found to have superior coverage (>80%) for four main pathologies: pneumonia, bacteremia, meningitis, and acute otitis media.\",\n\"answer_choice\": \"D\"\n}"]